p21-Activated kinase 4 promotes prostate cancer progression through CREB - PubMed (original) (raw)

. 2013 May 9;32(19):2475-82.

doi: 10.1038/onc.2012.255. Epub 2012 Jun 18.

Affiliations

• PMID: 22710715
• DOI: 10.1038/onc.2012.255

p21-Activated kinase 4 promotes prostate cancer progression through CREB

M-H Park et al. Oncogene. 2013.

Abstract

Prostate cancer is initially androgen-dependent but, over time, usually develops hormone- and chemo-resistance. The present study investigated a role for p21-activated kinase 4 (PAK4) in prostate cancer progression. PAK4 activation was markedly inhibited by H89, a specific protein kinase A (PKA) inhibitor, and PAK4 was activated by the elevation of cAMP. The catalytic subunit of PKA interacted with the regulatory domain of PAK4, and directly phosphorylated PAK4 at serine 474 (S474). Catalytically active PAK4 enhanced the transcriptional activity of CREB independent of S133 phosphorylation. Stable knockdown of PAK4 in PC-3 and DU145 prostate cancer cells inhibited tumor formation in nude mice. Decreased tumorigenicity correlated with decreased expression of CREB and its targets, including Bcl-2 and cyclin A1. Additionally, in androgen-dependent LNCap-FGC cells, PAK4 regulated cAMP-induced neuroendocrine differentiation, which is known to promote tumor progression. Finally, PAK4 enhanced survival and decreased apoptosis following chemotherapy. These results suggested that PAK4 regulates progression toward hormone- and chemo-resistance in prostate cancer, and this study identified both a novel activation mechanism and potential downstream effector pathways. Therefore, PAK4 may be a promising therapeutic target in prostate cancer.

PubMed Disclaimer

Similar articles

• The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer.
  Park JJ, Park MH, Oh EH, Soung NK, Lee SJ, Jung JK, Lee OJ, Yun SJ, Kim WJ, Shin EY, Kim EG. Park JJ, et al. Oncogene. 2018 Sep;37(38):5147-5159. doi: 10.1038/s41388-018-0327-8. Epub 2018 May 30. Oncogene. 2018. PMID: 29849120
• p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.
  Yun CY, You ST, Kim JH, Chung JH, Han SB, Shin EY, Kim EG. Yun CY, et al. J Invest Dermatol. 2015 May;135(5):1385-1394. doi: 10.1038/jid.2014.548. Epub 2015 Jan 5. J Invest Dermatol. 2015. PMID: 25560280
• PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity.
  Whale AD, Dart A, Holt M, Jones GE, Wells CM. Whale AD, et al. Oncogene. 2013 Apr 18;32(16):2114-20. doi: 10.1038/onc.2012.233. Epub 2012 Jun 11. Oncogene. 2013. PMID: 22689056 Free PMC article.
• PAK4 signaling in health and disease: defining the PAK4-CREB axis.
  Won SY, Park JJ, Shin EY, Kim EG. Won SY, et al. Exp Mol Med. 2019 Feb 12;51(2):1-9. doi: 10.1038/s12276-018-0204-0. Exp Mol Med. 2019. PMID: 30755582 Free PMC article. Review.
• Vitamin D autocrine system and prostate cancer.
  Wang L, Whitlatch LW, Flanagan JN, Holick MF, Chen TC. Wang L, et al. Recent Results Cancer Res. 2003;164:223-37. doi: 10.1007/978-3-642-55580-0_16. Recent Results Cancer Res. 2003. PMID: 12899525 Review.

Cited by

• Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling.
  Miklos W, Heffeter P, Pirker C, Hager S, Kowol CR, van Schoonhoven S, Stojanovic M, Keppler BK, Berger W. Miklos W, et al. Oncotarget. 2016 Dec 20;7(51):84556-84574. doi: 10.18632/oncotarget.11821. Oncotarget. 2016. PMID: 27602951 Free PMC article.
• p21-Activated Kinase 4 Signaling Promotes Japanese Encephalitis Virus-Mediated Inflammation in Astrocytes.
  He W, Zhao Z, Anees A, Li Y, Ashraf U, Chen Z, Song Y, Chen H, Cao S, Ye J. He W, et al. Front Cell Infect Microbiol. 2017 Jun 21;7:271. doi: 10.3389/fcimb.2017.00271. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28680855 Free PMC article.
• cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.
  Ahmed MB, Alghamdi AAA, Islam SU, Lee JS, Lee YS. Ahmed MB, et al. Cells. 2022 Jun 24;11(13):2020. doi: 10.3390/cells11132020. Cells. 2022. PMID: 35805104 Free PMC article. Review.
• p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond.
  Li X, Li F. Li X, et al. Cancers (Basel). 2022 Sep 28;14(19):4736. doi: 10.3390/cancers14194736. Cancers (Basel). 2022. PMID: 36230657 Free PMC article. Review.
• P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate.
  Wang Y, Gratzke C, Tamalunas A, Wiemer N, Ciotkowska A, Rutz B, Waidelich R, Strittmatter F, Liu C, Stief CG, Hennenberg M. Wang Y, et al. PLoS One. 2016 Apr 12;11(4):e0153312. doi: 10.1371/journal.pone.0153312. eCollection 2016. PLoS One. 2016. PMID: 27071060 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program